Masayo Takahashi

This inventor holds 19 USPTO granted patents and 15 published patent applications, plus 7 CIPO patents and 8 EPO patents, primarily in Retinal Tissue Engineering. Top assignees: Riken Corporation, Sumitomo Pharma Co., Ltd., Sumitomo Chemical Company, Limited. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayo Takahashi. Retrieved from https://idiyas.com/inventor/masayo-takahashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 15)

% Patents Active = 89.5

CIPO Patents = 7 (Patent Applications = 15)

EPO Patents = 8 (Patent Applications = 16)

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 23(Granted Patents)

Location History:

Hyogo, JP (2019)
Saitama, JP (2019)
Kobe, JP (2015 - 2022)
Wako, JP (2018 - 2024)

Company Filing History:

Sumitomo Pharma Co., Ltd.

patents

3 out of 6,964

Sumitomo Chemical Company, Limited

Sumitomo Dainippon Pharma Co., Ltd.

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Retinal Pigment Epithelium

Neural Retina

Dopaminergic Neurons

Retinal Progenitor Cells

Nerve Tissue

Hydrogel Composite

Cell Aggregates

Photoreceptor Cells

Transplantation Methods

Eye Disease Treatment

Cell Production Methods

Medical Instruments

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12595464 - METHOD OF PRODUCING RETINAL PIGMENT EPITHELIAL CELL (2026-04-07),

2. 12533382 - Composite including neural retina, retinal pigment epithelial cells, and hydrogel, and method for producing same (2026-01-27),

3. 12516286 - Method for producing dopaminergic neuron progenitor cell (2026-01-06),

4. 12492373 - Production method for nerve tissue (2025-12-09),

5. 12291720 - Production method for retinal tissue (2025-05-06),

6. 12285543 - Human cell population comprising human retinal progenitor cells without an ISL1 gene for transplantation and methods of use thereof (2025-04-29),

7. 12090252 - Method for producing retinal tissues (2024-09-17),

8. 11898163 - Method for producing dopaminergic neuron progenitor cell (2024-02-13),

9. 11684698 - Cell aggregate including retinal tissue and production method therefor (2023-06-27),

10. 11421203 - Method of producing human retinal pigment epithelial cells (2022-08-23),

11. 11371016 - Method for producing retinal tissue (2022-06-28),

12. 11214772 - Production method for retinal tissue (2022-01-04),

13. 11214771 - Production method for nerve tissue (2022-01-04),

14. 11033586 - Method for producing retinal pigment epithelial cell sheet (2021-06-15),

15. 10519422 - Method of producing human retinal pigment epithelial cells (2019-12-31),

Title: The Remarkable Journey of Inventor Masayo Takahashi

Introduction: Masayo Takahashi is a pioneering female inventor hailing from Wako, Japan. She has made significant contributions to the field of regenerative medicine and ophthalmology through her groundbreaking innovations.

Latest Patents: As of the latest data available, Masayo Takahashi holds several patents related to stem cell research and its applications in treating various eye diseases. Her patents showcase her dedication to advancing medical science for the benefit of patients worldwide.

Career Highlights: Masayo Takahashi's career is highlighted by her role as a leading researcher at the RIKEN Center for Developmental Biology in Japan. She gained international recognition for her work on induced pluripotent stem cells (iPSCs) and their potential in regenerative medicine.

Collaborations: Throughout her career, Masayo Takahashi has collaborated with top scientists and medical professionals in the field of ophthalmology and regenerative medicine. Her collaborative efforts have led to significant advancements in the development of innovative treatments for eye disorders.

Conclusion: In conclusion, Masayo Takahashi's dedication to pushing the boundaries of science and medicine has established her as a prominent figure in the field of regenerative medicine. Her innovative spirit and commitment to improving healthcare continue to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.